The lowest representation of Black individuals in GLP-1 RA trials was 2.3% in “Albiglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Cardiovascular Disease (HARMONY OUTCOMES)” (25) (Figure 1B). Here, GLP1R is linked to type 2 diabetes mellitus.